Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21234772

Switching to duloxetine in selective serotonin reuptake inhibitor non-and partial-responders : Effects on painful physical symptoms of depression

Author
PERAHIA, David G. S1 2 ; QUAIL, Deborah1 ; DESAIAH, Durisala3 ; MONTEJO, Angel L4 ; SCHATZBERG, Alan F5
[1] Lilly Research Centre, EMC Building, Erl Wood Manor, Sunninghill Road, Windlesham CU20 6PH, Surrey, United Kingdom
[2] The Gordon Hospital, London, United Kingdom
[3] Eli Lilly and Company, Indianapolis, IN, United States
[4] University Hospital of Salamanca, Spain
[5] Stanford University School of Medicine, Stanford, CA, United States
Source

Journal of psychiatric research. 2009, Vol 43, Num 5, pp 512-518, 7 p ; ref : 3/4 p

CODEN
JPYRA3
ISSN
0022-3956
Scientific domain
Cognition; Psychology, psychopathology, psychiatry
Publisher
Elsevier, Kidlington
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
Depression Duloxetine Painful physical symptoms Switch
Keyword (fr)
Antidépresseur Changement médicament Douleur Duloxétine Efficacité traitement Etat dépressif Etude longitudinale Homme Inhibiteur sélectif recapture sérotonine Pharmacothérapie Psychotrope Symptomatologie Symptôme physique Catécholamine Inhibiteur recapture Neurotransmetteur Noradrénaline Sérotonine Traitement Trouble de l'humeur
Keyword (en)
Antidepressant agent Drug conversion Pain Duloxetine Treatment efficiency Depression Follow up study Human Selective serotonin reuptake inhibitor Pharmacotherapy Psychotropic Symptomatology Catecholamine Reuptake inhibitor Neurotransmitter Norepinephrine Serotonin Treatment Mood disorder
Keyword (es)
Antidepresor Cambio medicamento Dolor Duloxetina Eficacia tratamiento Estado depresivo Estudio longitudinal Hombre Inhibidor selectivo recaptura serotonin Farmacoterapia Psicotropo Sintomatología Catecolamina Inhibidor recaptura Neurotransmisor Noradrenalina Serotonina Tratamiento Trastorno humor
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer…

Discipline
Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
Origin
Inist-CNRS
Database
FRANCIS ; PASCAL
INIST identifier
21234772

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web